196 related articles for article (PubMed ID: 36531013)
1. Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets
Chen B; Mao T; Qin X; Zhang W; Watanabe N; Li J
Front Oncol; 2022; 12():1029998. PubMed ID: 36531013
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
3. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
4. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of hub genes and key pathway in two subtypes of diffuse large B-cell lymphoma by bioinformatics and basic experiments.
Li Q; Meng Y; Hu L; Charwudzi A; Zhu W; Zhai Z
J Clin Lab Anal; 2021 Nov; 35(11):e23978. PubMed ID: 34545634
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
7. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma.
Charwudzi A; Meng Y; Hu L; Ding C; Pu L; Li Q; Xu M; Zhai Z; Xiong S
PeerJ; 2021; 9():e12394. PubMed ID: 34760386
[TBL] [Abstract][Full Text] [Related]
10. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
11. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
12. Identification of Hub Genes and Pathways Associated with CAR-T Cell-Mediated Neurotoxicity in DLBCL.
Wang Y; Li B; Wang Z; Li C; Bi G; Liu G; Teng Q; Guo D
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383407
[TBL] [Abstract][Full Text] [Related]
13. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome analysis revealed CENPF associated with glioma prognosis.
Zhang M; Zhang Q; Bai J; Zhao Z; Zhang J
Math Biosci Eng; 2021 Mar; 18(3):2077-2096. PubMed ID: 33892537
[TBL] [Abstract][Full Text] [Related]
17. Identifying potential prognosis markers in hepatocellular carcinoma
Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
Front Genet; 2022; 13():942454. PubMed ID: 35928445
[No Abstract] [Full Text] [Related]
18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
19. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
20. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]